Is Matinas BioPharma Holdings, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for Matinas BioPharma Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish while the monthly MACD is mildly bullish, indicating some positive momentum. The weekly RSI is bearish, contrasting with the monthly RSI which is bullish, suggesting mixed signals across time frames. The daily moving averages are bullish, supporting a short-term positive outlook. However, Bollinger Bands show a mildly bullish weekly stance but a bearish monthly stance, adding to the mixed signals.
In terms of performance, the stock has a year-to-date return of 239.22%, significantly outperforming the S&P 500's 12.22% during the same period, but it has underperformed over the longer term with a 1-year return of -50.85% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, but the strength is tempered by conflicting indicators and longer-term underperformance.